Supplier
NOVOPHAR SA
R213437810016
Total received
- Contracts
- 34
- Agencies that bought from them
- 15
- Average contract
- $ 147.940
- Years with activity
- 3
- First contract
- 28 jun. 2023
- Last contract
- 05 oct. 2026
NOVOPHAR SA received $ 5 M from the Uruguayan state across 34 awards between 2024 and 2026. It sold to 15 agencies. Its largest buyer is Presidencia de la República y Unidades Dependientes, with 93% of recorded spending.
What it bid for, and against whom
Open data publishes only the winner, so losing bids appear nowhere. This comes from the bidders each purchase record publishes. It covers the 122 calls of this company we have checked so far, not all of them: the scan advances gradually.
Who it meets most often
- MEGALABS URUGUAY S A105 times
- LABORATORIOS CELSIUS S A93 times
- LABORATORIO GADOR S A89 times
- GRAMON BAGO DE URUGUAY S A83 times
- FARMACO URUGUAYO S.A.77 times
- ICU VITA S A77 times
- EUROFARMA URUGUAY SOCIEDAD ANONIMA72 times
- LABORATORIO LIBRA SOCIEDAD ANONIMA71 times
State Suppliers Registry (RUPE)
ACTIVO- Legal name
- NOVOPHAR SA
- Fiscal domicile
- Montevideo PLAZA INDEPENDENCIA 831 Apto. 308 View on Google Maps
Source: ARCE — Registro Único de Proveedores del Estado (RUPE), open data. Cross-referenced to the supplier by RUT.
Revenue by year
Who buys from them
Agencies ranked by amount awarded to this supplier.
- Presidencia de la República y Unidades Dependientes$ 5,68 mil M
- Dirección Nacional de Sanidad de las Fuerzas Armadas$ 190 M
- Banco de Seguros del Estado$ 152 M
- Dirección Nacional de Sanidad Policial$ 28,7 M
- Banco de Previsión Social$ 7,7 M
Client concentration
93%
Presidencia de la República y Unidades Dependientes
How much of their revenue comes from their largest buyer.
Contracts
View all| Subject | Agency | Date | Amount |
|---|---|---|---|
| PASTA PROFILACTICA SIN FLUOR (SELLANTE) · SALBUTAMOL (INYECTABLE)… | Centro Departamental de Rocha | 05 oct. 2026 | $ 166.117 |
| ADENOSINA (INYECTABLE) · FORMULA PARA LACTANTE EN BASE A LECHE DE VACA | Banco de Previsión Social | 05 oct. 2026 | $ 20.395 |
| SUPLEMENTO NUTRICIONAL ENTERAL ESPECIFICO · MALTODEXTRINA DE MAIZ… | Banco de Previsión Social | 16 set. 2026 | $ 1,3 M |
| GLICEROFOSFATO DE SODIO (INYECTABLE) · PARACETAMOL (INYECTABLE)… | Centro Hospitalario Pereira Rossell | 14 set. 2026 | $ 3,6 M |
| IODOPOVIDONA (SOLUCION) · ALPRAZOLAM (COMPRIMIDOS)… | Hospital de San Carlos | 11 set. 2026 | $ 2,2 M |
| FORMULA PARA LACTANTE EN BASE A LECHE DE VACA | Centro Departamental de Durazno | 07 set. 2026 | $ 19.672 |
| FORMULA PARA LACTANTE EN BASE A LECHE DE VACA | Centro Departamental de Flores | 07 set. 2026 | $ 54.000 |
| DOXICICLINA (COMPRIMIDOS) · COLECALCIFEROL (COMPRIMIDOS)… | Centro Departamental de Durazno | 03 set. 2026 | $ 405.870 |
63 suppliers